Download presentation
Presentation is loading. Please wait.
Published byGlenna Santoso Modified over 5 years ago
1
Characteristics of Patients With AAA and of Control Subjects
Manon C. Zweers, et al, Circulation. 2006;113:
2
A, Tenascin-X is abundantly expressed in normal human aorta
A, Tenascin-X is abundantly expressed in normal human aorta. B, Immunofluorescent staining of normal aortic wall shows colocalization of elastin (red) and tenascin-X (green). Overlapping expression is shown in yellow. C, The presence of tenascin-X is decreased in AAA. Manon C. Zweers, et al, Circulation. 2006;113:
3
Risk of Having an AAA in Strata of Tenascin-X Serum Concentrations
Manon C. Zweers, et al, Circulation. 2006;113:
4
Risk of Peripheral Vascular Disease (PVD) in Strata of Tenascin-X Concentrations
Manon C. Zweers, et al, Circulation. 2006;113:
5
Effect of Surgery on AAA Risk in Strata of Tenascin-X Serum Concentrations
Manon C. Zweers, et al, Circulation. 2006;113:
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.